Get the Stockscreener App
6.77
2.17%
-0.15
Tango Therapeutics Inc stock is traded at $6.77, with a volume of 1.02M.
It is down -2.17% in the last 24 hours and up +14.55% over the past month.
Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.
See More
Previous Close:
$6.92
Open:
$6.97
24h Volume:
1.02M
Relative Volume:
0.33
Market Cap:
$753.23M
Revenue:
$42.51M
Net Income/Loss:
$-116.49M
P/E Ratio:
-6.0446
EPS:
-1.12
Net Cash Flow:
$-120.82M
1W Performance:
+2.42%
1M Performance:
+14.55%
6M Performance:
+174.09%
1Y Performance:
-27.98%
1-Day Range:
$6.761
$7.01
1-Week Range:
$6.265
$7.15
52-Week Range:
$1.03
$12.02
Tango Therapeutics Inc Stock (TNGX) Company Profile
Name
Tango Therapeutics Inc
Sector
Industry
Phone
(857) 320-4900
Address
201 BROOKLINE AVENUE, BOSTON
Compare TNGX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TNGX
Tango Therapeutics Inc
|
6.77 | 769.92M | 42.51M | -116.49M | -120.82M | -1.12 |
|
VRTX
Vertex Pharmaceuticals Inc
|
392.79 | 100.07B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.41 | 59.99B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
448.91 | 58.03B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
653.83 | 39.93B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
321.36 | 36.82B | 3.81B | -644.79M | -669.77M | -6.24 |
Tango Therapeutics Inc Stock (TNGX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-17-24 | Initiated | Jefferies | Buy |
| Apr-04-24 | Initiated | Cantor Fitzgerald | Overweight |
| Feb-12-24 | Initiated | Piper Sandler | Overweight |
| Dec-08-23 | Initiated | B. Riley Securities | Buy |
| Oct-20-22 | Upgrade | H.C. Wainwright | Neutral → Buy |
| Sep-20-21 | Initiated | SVB Leerink | Outperform |
View All
Tango Therapeutics Inc Stock (TNGX) Latest News
Can swing trading help recover from Tango Therapeutics Inc. lossesJuly 2025 Technicals & Long-Term Safe Investment Ideas - Newser
Applying big data sentiment scoring on Tango Therapeutics Inc.Weekly Gains Report & Verified Momentum Stock Alerts - Newser
Analyzing Tango Therapeutics Inc. with risk reward ratio charts2025 Technical Overview & Fast Entry High Yield Stock Tips - Newser
What’s next for Tango Therapeutics Inc. stock priceWeekly Investment Report & Entry Point Strategy Guides - Newser
Using Python tools to backtest Tango Therapeutics Inc. strategiesDollar Strength & High Conviction Investment Ideas - Newser
Advanced analytics toolkit walkthrough for Tango Therapeutics Inc.Quarterly Market Review & Long-Term Growth Portfolio Plans - Newser
Tango Therapeutics Inc. recovery potential after sell off2025 Price Momentum & Daily Market Momentum Tracking - Newser
What Fibonacci levels say about Tango Therapeutics Inc. rebound2025 Trading Recap & Technical Entry and Exit Alerts - Newser
Why Tango Therapeutics Inc. stock attracts strong analyst attention2025 Top Decliners & AI Driven Price Predictions - Newser
What machine learning models say about Tango Therapeutics Inc.Market Sentiment Report & Daily Profit Focused Screening - Newser
Tango Therapeutics Inc. stock chart pattern explainedJuly 2025 Summary & Free Technical Confirmation Trade Alerts - Newser
Applying Elliott Wave Theory to Tango Therapeutics Inc.July 2025 Opening Moves & Fast Entry and Exit Trade Plans - Newser
How moving averages guide Tango Therapeutics Inc. tradingEarnings Performance Report & Risk Managed Trade Strategies - Newser
Price action breakdown for Tango Therapeutics Inc.Market Risk Summary & Technical Buy Zone Confirmations - Newser
Technical Charts Suggest Momentum Shift in Tango Therapeutics Inc. - sundaytimes.kr
Tango Therapeutics Inc. At Critical Juncture — Bounce or BreakdownPortfolio Update Summary & Entry Point Confirmation Alerts - metal.it
Full technical analysis of Tango Therapeutics Inc. stockBull Run & Verified Trade Idea Suggestions - Newser
B. Riley Forecasts Increased Earnings for Tango Therapeutics - Defense World
Is Tango Therapeutics Inc. gaining market shareJuly 2025 Action & Stepwise Entry and Exit Trade Signals - kangso.co.kr
Tango Therapeutics, Inc. (NASDAQ:TNGX) Shares Acquired by XTX Topco Ltd - Defense World
Tango Therapeutics Inc. stock chart pattern explained [Weekly Trend Recap]Growth Focused Stock Pick Reports - Newser
Is Tango Therapeutics Inc. stock a value trapBig Profit Trading Alerts - thegnnews.com
What candlestick patterns are forming on Tango Therapeutics Inc.Free Reliable Chart-Based Trade Entries - Newser
Tango Therapeutics Inc. Company Revenue and Profit Trends: A Deep DivePattern Breakout Prediction for Short Term - Newser
Need To Know: Analysts Are Much More Bullish On Tango Therapeutics, Inc. (NASDAQ:TNGX) - 富途牛牛
How high can Tango Therapeutics Inc. stock price go in 2025Oversold Reversal Picks with Buy Zone - Newser
Will Tango Therapeutics Inc. see short term momentumTrade Plan With Low Risk High Return - Newser
Tango Therapeutics Inc Stock (TNGX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.41%
0.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):